Professor Susana Banerjee (MBBS MA PhD FRCP) is a Consultant Medical Oncologist and Research Lead within the Gynaecology Unit at London's, The Royal Marsden. She is Professor in Women's Cancers and Team Leader at the Institute of Cancer Research.
Professor Susana Banerjee (MBBS MA PhD FRCP) is a Consultant Medical Oncologist and Research Lead within the Gynaecology Unit at London's, The Royal Marsden. She is Professor in Women's Cancers and Team Leader at the Institute of Cancer Research.
Banerjee has a First-Class degree in Physiology from St John’s College, University of Cambridge. [1] She was President of the Cambridge Medical Society (1996-1997). She completed her medical training in 2000 at The Royal Free / University College London Medical School, where she was a University of London Gold Medal finalist. In 2009, she obtained her PhD from the Institute of Cancer Research, University of London, and her research received the San Antonio Breast Cancer Symposium Novartis Oncology Basic Science Award. She received the Association of Cancer Physicians McElwain Prize, the Sir Antony Driver Prize, and the Pfizer British Oncology Association Young Investigator Award. In 2023 Banerjee received the Fellow of ESMO (FESMO) Award.
Banerjee participates in various international specialist groups. In the field of oncology, Banerjee has contributed to the European Society of Medical Oncology (ESMO), [2] Serving as Executive Board as Director of Membership (2020-2022). She was Track Chair for Gynaecological Cancers for the ESMO Congress 2018, Scientific Co-Chair for ESMO Asia 2018 and Co-Chair of the ESMO Gynaecological Cancers Congress 2021-2024. She is currently co-chair of the Gynecological Cancer InterGroup (GCIG) Rare Cancers Committee. She is a Theme Lead (Cancer Treatment Effects) for the National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research. She has served in the European Organization for Research and Treatment of Cancer (EORTC), [3] Executive Steering Committee for Gynaecological Cancers, engagement as a faculty member of ESGO (European Society of Gynaecological Oncology) [4] Congress, and her role within the International Gynecological Cancer Society Scientific Program Committee.
Banerjee is a researcher working in clinical trials collaborating with leading scientists on early-phase studies, contributing to the development of drug treatments. Her body of work comprises over 175 peer-reviewed publications. [5] [6]
Banerjee is a Board Member of the International Cancer Foundation Board. [7]
The Institute of Cancer Research is a public research institute and a member institution of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003. It has been responsible for a number of breakthrough discoveries, including that the basic cause of cancer is damage to DNA.
The International Federation of Gynaecology and Obstetrics, usually just FIGO ("fee'go") as the acronym of its French name Fédération Internationale de Gynécologie et d'Obstétrique, is a worldwide non-governmental organisation representing obstetricians and gynaecologists in over one hundred territories. It was founded on 26 July 1954 in Geneva, Switzerland, to "promote the well-being of women and to raise the standard of practice in obstetrics and gynaecology". Membership is currently composed of 132 professional societies of obstetricians and gynaecologists worldwide.
Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of these cancers.
Martine J. Piccart-Gebhart is a Belgian medical oncologist. She is a professor of oncology at the Université Libre de Bruxelles and scientific director at the Jules Bordet Institute in Brussels, Belgium. She is also a member of the Belgian Royal Academy of Medicine.
The European Society of Gynaecological Oncology (ESGO) is a Europe-wide society of health care professionals and researchers specializing in the study, prevention, treatment and care of gynaecological cancers. The society, which has more than 2,600 members worldwide, was founded in Venice, Italy, in 1983.
Oncology is a branch of medicine that deals with the study, treatment, diagnosis, and prevention of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass". Oncology is concerned with:
Professor Dame Janet Elizabeth Husband is Emeritus Professor of Radiology at the Institute of Cancer Research. She had a career in diagnostic radiology that spanned nearly 40 years, using scanning technology to diagnose, stage, and follow-up cancer. She continues to support medicine and research as a board member and advisor for various organisations.
The European Society for Medical Oncology (ESMO) is the leading professional organisation for medical oncology. With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO was founded in 1975.
Peter Boyle, FRSE FFPH FRCPS(Glas) FRCP(Edin) FMedSci, was a British epidemiologist. He conducted research on globalisation of cancer, where he showed the dramatic increase of cancer in low- and medium income countries.
Professor Henry Kitchener, MD FRCOG FRCS(Glas) FMedSci, is a leading British expert in gynaecological oncology, based at the University of Manchester. He is a fellow of the Academy of Medical Sciences.
Patrick Schöffski is a German medical doctor specializing in internal medicine, hematology and medical oncology.
Christopher M. Nutting is a British Professor of Clinical Oncology and medical consultant, specializing in head and neck cancers, who has helped develop Intensity-Modulated Radiotherapy (IMRT), an advanced form of Radiation therapy.
Lalit Kumar is an Indian oncologist, known to have contributed to the development of low cost medical facilities in Delhi. The Government of India honoured him, in 2014, with the award of Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine.
Frances Alice Shepherd, is a Canadian oncologist recognized for her research on lung cancer and her contributions to the design, development, and conduct of clinical trials. She is currently a senior staff physician at Princess Margaret Cancer Centre, where she has held the Scott Taylor Chair in Lung Cancer Research since 2001, and she is a full professor in the Department of Medicine at the University of Toronto.
Helga Birgitte Salvesen was a Norwegian physician and professor of medicine at the University of Bergen.
The Lady Garden Foundation, previously the Gynaecological Cancer Fund, was formed in 2014 in the United Kingdom. The foundation was started by a group of women, all of whom had been affected by gynaecological cancer in some capacity.
Sarah Coupland is an Australian-born pathologist and professor who is the George Holt Chair in Pathology at the University of Liverpool. Coupland is an active clinical scientist whose research focuses on the molecular genetics of cancers, with particular interests in uveal melanoma, conjunctival melanoma, intraocular and ocular adnexal lymphomas and CNS lymphoma. Coupland is also an NHS Honorary Consultant Histopathologist at the Royal Liverpool University Hospital. Since 2006, Coupland has been head of the Liverpool Ocular Oncology Research Group; from which she runs a multidisciplinary oncology research group focussing on Uveal melanoma, based in the Department of Molecular and Clinical Cancer Medicine at the University of Liverpool. Her research laboratory is currently located in the Institute of Translational Medicine From April 2014 to December 2019, Coupland was also Director of the North West Cancer Research Centre, @UoL. In both 2019 and 2020, Coupland was included on the 'Pathology Powerlist' on The Pathologist website.
Beth Young Karlan is an American gynecologic oncologist. In 2008, she was named editor-in-chief of the medical journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012, Karlan was appointed by the White House to serve on the National Cancer Advisory Board, and in 2015, she was elected to the National Academy of Medicine.
Rolf Kreienberg was a German gynaecologist and obstetrician.
Sophie Postel-Vinay is a French physician and scientist at the Institut Gustave Roussy where she has led an ATIP-Avenir team since 2018. She works on oncology and the development of new drugs and is an expert in early clinical trials. She was the 2019 winner of the Irène Joliot-Curie Prize in the “young woman scientist” category.
| Authority control databases: Academics |
|---|
